RECITALSEmployment Agreement • December 31st, 2001 • Alpharx Inc • Pharmaceutical preparations
NO. W - A -___ Warrant for _____________ Common Stock (subject to adjustment) ALPHARX, INC. WARRANT TO PURCHASE COMMON STOCK This certifies that, for value received, __________________________, a ___________ organized and existing under the laws of...Warrant Agreement • October 5th, 2004 • Alpharx Inc • Pharmaceutical preparations
Exhibit 10.3 EMPLOYMENT AGREEMENT WITH JOSEPH SCHWARZ EMPLOYMENT AGREEMENT ("Agreement") made and entered into as of the 1st day of July, 2000 by and between AlphaRx Inc., a Delaware corporation ("Company"), and Joseph Schwarz ("Executive"). WHEREAS,...Employment Agreement • December 31st, 2001 • Alpharx Inc • Pharmaceutical preparations • Delaware
Exhibit 10.2 EMPLOYMENT AGREEMENT WITH MICHAEL M. LEE EMPLOYMENT AGREEMENT ("Agreement") made and entered into as of the 1st day of July, 2000 by and between AlphaRx Inc., a Delaware corporation ("Company"), and Michael M. Lee ("Executive"). WHEREAS,...Employment Agreement • December 31st, 2001 • Alpharx Inc • Pharmaceutical preparations • Delaware
AMENDMENT AGREEMENTEmployment Agreement • December 31st, 2001 • Alpharx Inc • Pharmaceutical preparations
WARRANT TO PURCHASE COMMON STOCK EXHIBIT 4(III) THIS SECURITY HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY APPLICABLE STATE SECURITIES LAWS, AND MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE...Warrant to Purchase Common Stock • September 30th, 2004 • Alpharx Inc • Pharmaceutical preparations
Exhibit 10.5 EMPLOYMENT AGREEMENT WITH SAI MING WONG EMPLOYMENT AGREEMENT ("Agreement") made and entered into as of the 1st day of July, 2000 by and between AlphaRx Inc., a Delaware corporation ("Company"), and Sai Ming Wong ("Executive"). WHEREAS,...Employment Agreement • December 31st, 2001 • Alpharx Inc • Pharmaceutical preparations • Delaware
AMENDMENT AGREEMENTEmployment Agreement • December 31st, 2001 • Alpharx Inc • Pharmaceutical preparations
EXHIBIT 4(ii) AMENDMENT TO THE SUBSCRIPTION AGREEMENTSubscription Agreement • October 5th, 2004 • Alpharx Inc • Pharmaceutical preparations
The undersigned, as a signatory to a subscription agreement with AlphaRx, Inc., executed in conjunction with that certain offering of units, consisting of one share of AlphaRx's common stock and one warrant for one additional share of AlphaRx's common stock, for up to $5,000,000 (the "Agreement") for good and valuable consideration, the adequacy and sufficiency of which is hereby acknowledged, does hereby agree that the deadline for the final closing on page 3 of the Agreement is hereby amended from August 15, 2004 to September 30, 2004.
JOINT VENTURE AGREEMENT ______________ among BASIN INDUSTRIAL LIMITED and ALPHARX INTERNATIONAL HOLDINGS LIMITED and ALPHA AP INC.Joint Venture Agreement • June 6th, 2005 • Alpharx Inc • Pharmaceutical preparations • New York
This Joint Venture Agreement ("Agreement") is entered into as of this 22nd day of April, 2005 between Basin Industrial Limited, a British Virgin Islands corporation located at 12 Dai Fu Street, Tai Po Industrial Estate, Tai Po, New Territories, Hong Kong ("Basin"), AlphaRx International Holdings Limited, a British Virgin Islands corporation located at Unit A, 19/F Sang Woo Building, Nos. 227-228, Gloucester Road, Causeway Bay Hong Kong ("AIH"), and Alpha AP Inc., a British Virgin Islands corporation located at c/o Advance Pharmaceutical Co., Ltd., 12 Dai Fu Street, Tai Po Industrial Estate, Tai Po, New Territories, Hong Kong ("Alpha").
AGREEMENTAcquisition Agreement • August 31st, 2012 • Alpharx Inc • Pharmaceutical preparations • Delaware
This AGREEMENT (this “Agreement”), dated as of August 29, 2012, is by and among AlphaRx, Inc., a Delaware corporation (the “Parent”), UMeLook Holdings Limited, a corporation formed pursuant to the laws of the British Virgin Islands (the “Company”), UMeLook Limited, a corporation formed pursuant to the laws of Hong Kong which is the wholly owned subsidiary of the Company (“UMeLook Limited”) and the shareholders of the Company (each a “Shareholder” and collectively the “Shareholders”). Each of the parties to this Agreement is individually referred to herein as a “Party” and collectively as the “Parties.”
SECURITY AGREEMENTSecurity Agreement • August 22nd, 2011 • Alpharx Inc • Pharmaceutical preparations • Delaware
This Security Agreement (“Agreement”) is made as of August 22, 2011 by and among AlphaRx, Inc., a Delaware corporation (the “Debtor”), and the parties listed on Schedule A under heading Secured Parties (each a “Secured Party”, and collectively the “Secured Parties”).
MANUFACTURING AND DISTRIBUTION LICENSE AGREEMENT THIS AGREEMENT, effective this 1st day of September, 2003,Manufacturing and Distribution License Agreement • July 8th, 2005 • Alpharx Inc • Pharmaceutical preparations
ALPHARX INC., a corporation incorporated under the laws of the State of Delaware, United States of America, and having its principal place of business at 10-75 East Beaver Creek, Richmond Hill, Ontario, Canada L4B 1B8
MANUFACTURING AND DISTRIBUTION LICENSE AGREEMENT THIS AGREEMENT, effective this 22nd day of April, 2005,Manufacturing and Distribution License Agreement • June 6th, 2005 • Alpharx Inc • Pharmaceutical preparations • New York
AlphaRx International Holdings Limited, a corporation incorporated under the laws of the British Virgin Islands, and having its principal place of business at Unit A, 19/F Sang Woo Building, Nos. 227-228, Gloucester Road, Causeway Bay Hong Kong.
FIRST AMENDMENT TO "MANUFACTURING AND DISTRIBUTION LICENSE AGREEMENT"Manufacturing and Distribution License Agreement • June 29th, 2005 • Alpharx Inc • Pharmaceutical preparations
This First Amendment is dated 22nd June 2005, and is made between AlphaRx International Holdings Limited ("AIH"), a corporation incorporated under the laws of the British Virgin Islands, and having its principal place of business at Unit A, 19/F Sang Woo Building, Nos. 227-228, Gloucester Road, Causeway Bay, Hong Kong and Alpha AP Inc. ("AAP"), a corporation incorporated under the laws of the British Virgin Islands, and having its principal office c/o Advance Pharmaceutical Co., Ltd., 2/F, 12 Dai Fu Street, Tai Po Industrial Estate, Tai Po, New Territories, Hong Kong.
